Pharmacodynamic Modelling of Biomarker Data in Oncology
The development of pharmacodynamic (PD) biomarkers in oncology has implications for design of clinical protocols from preclinical data and for predicting clinical outcomes from early clinical data. Two classes of biomarkers have received particular attention. Phosphoproteins in biopsy samples are ma...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
International Scholarly Research Network
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302113/ |